BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 22/08/2018

FDA Clears DITROPAN XL for Approval After Safety Review

The FDA has determined that DITROPAN XL (oxybutynin chloride) Extended Release Tablets, 15 mg, were not withdrawn from sale due to safety concerns, paving the way for potential approval of abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →